Cargando...
Pilocytic astrocytoma: pathology, molecular mechanisms and markers
Pilocytic astrocytomas (PAs) were recognized as a discrete clinical entity over 70 years ago. They are relatively benign (WHO grade I) and have, as a group, a 10-year survival of over 90 %. Many require merely surgical removal and only very infrequently do they progress to more malignant gliomas. Wh...
Guardado en:
| Publicado en: | Acta Neuropathol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4436848/ https://ncbi.nlm.nih.gov/pubmed/25792358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00401-015-1410-7 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|